PATENT CLAIM ANALYSIS

Application Number: 15748622
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-01
Patent Classification: ["514", "017200"]

Abstract:
The present invention relates to a pharmaceutical composition for preventing or treating dry eye, the pharmaceutical composition including, as an active component, a novel peptide is disclosed, wherein it is confirmed that the peptide has effects on improving tear production and corneal surface smoothness for dry eyes induced by desiccation stress and suppressing detachment of corneal epithelial cells, reduction in conjunctival goblet cells, and generation of inflammatory factors, thereby applying a composition including the peptide as an active component to the pharmaceutical composition for preventing or treating dry eye.

Claim (Index 5):
The method of  claim 1 , wherein the peptide having the amino acid sequence of SEQ ID NO: 1 or 2 recovers a production of tears that have been reduced by desiccation stress and an imbalance in a corneal surface, and suppresses detachment of corneal epithelial cells and production of inflammatory factors.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 86.0
- Lexical Diversity: 1.64407
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15552529', '15611025', '15125357', '15775835', '12709895']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7580848083004695
- 35 USC 102 Novelty (BERT): 0.5087715338978308
- Combined Prediction Score: 0.7331534808602056
- Mean Citation Score: 211.035994
- Max Citation Score: 220.9922
- Similarity Product: 132.6162953500986

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test